Limits...
BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells.

Tassone P, Tagliaferri P, Perricelli A, Blotta S, Quaresima B, Martelli ML, Goel A, Barbieri V, Costanzo F, Boland CR, Venuta S - Br. J. Cancer (2003)

Bottom Line: HCC1937 cells were significantly (P<0.005) more sensitive to cisplatin (CDDP) (IC(50) : 30-40 microM) compared with MCF-7 (IC(50) : 60-70 microM) and MDA-MB231 (IC(50) : 90-100 microM) cells.Full-length BRCA1 cDNA transfection of BRCA1-defective HCC1937 cells led to the reconstituted expression of BRCA1 protein in HCC1937/(WT)BRCA1-derived cell clone, but did not reduce tumour cell growth in soft agar.BRCA1 reconstitution reverted the hypersensitivity to CDDP (P<0.02), and restored the sensitivity to Dox (P<0.05) and Tax (P<0.001), compared with parental HCC1937 cells.

View Article: PubMed Central - PubMed

Affiliation: Department of Experimental and Clincal Medicine, 'Magna Graecia' University, Italy. tassone@unicz.it

ABSTRACT
Germline mutations of the tumour suppressor gene BRCA1 are involved in the predisposition and development of breast cancer and account for 20-45% of all hereditary cases. There is an increasing evidence that these tumours are characterised by a specific phenotype and pattern of gene expression. We have hypothesised that differences in chemosensitivity might parallel molecular heterogeneity of hereditary and sporadic breast tumours. To this end, we have investigated the chemosensitivity of the BRCA1-defective HCC1937 breast cancer cell line, and the BRCA1-competent MCF-7 (hormone-sensitive) and MDA-MB231 (hormone-insensitive) breast cancer cell lines using the MTT assay. The 50% inhibitory concentration (IC(50)) for the individual compounds were derived by interpolate plot analysis of the logarithmic scalar concentration curve after a 48 h exposure. HCC1937 cells were significantly (P<0.005) more sensitive to cisplatin (CDDP) (IC(50) : 30-40 microM) compared with MCF-7 (IC(50) : 60-70 microM) and MDA-MB231 (IC(50) : 90-100 microM) cells. On the other hand, BRCA1-defective breast cancer cells were significantly less sensitive to doxorubicin (Dox) (IC(50) : 45-50 microM) compared with MCF-7 (IC(50) : 1-5 microM) and MDA-MB231 (IC(50) : 5-10 microM) (P<0.02), as well as to paclitaxel (Tax) (IC(50) : >2 microM for HCC1937, 0.1-0.2 microM for MCF-7 and 0.01-0.02 microM for MDA-MB231) (P<0.001). Full-length BRCA1 cDNA transfection of BRCA1-defective HCC1937 cells led to the reconstituted expression of BRCA1 protein in HCC1937/(WT)BRCA1-derived cell clone, but did not reduce tumour cell growth in soft agar. BRCA1 reconstitution reverted the hypersensitivity to CDDP (P<0.02), and restored the sensitivity to Dox (P<0.05) and Tax (P<0.001), compared with parental HCC1937 cells. Taken together, our findings suggest a specific chemosensitivity profile of BRCA1-defective cells in vitro, which is dependent on BRCA1 protein expression, and suggest prospective preclinical and clinical investigation for the development of tailored therapeutical approaches in this setting.

Show MeSH

Related in: MedlinePlus

Differential sensitivity among BRCA1-defective and BRCA1-competent cells to Tax. In (A) HCC1937 cells, (B) MCF-7 cells and (C) MDA-MB231 cells, the dose-related activity of Tax is shown. Interpolate logarithmic curve and the IC50 of cell growth are shown in each quadrant. In (D), the value of IC50 determined for each cell line is shown. *: Maximum of concentration used, no IC50 was achieved at this dose of drug. ° and °°: P<0.001.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2747554&req=5

fig3: Differential sensitivity among BRCA1-defective and BRCA1-competent cells to Tax. In (A) HCC1937 cells, (B) MCF-7 cells and (C) MDA-MB231 cells, the dose-related activity of Tax is shown. Interpolate logarithmic curve and the IC50 of cell growth are shown in each quadrant. In (D), the value of IC50 determined for each cell line is shown. *: Maximum of concentration used, no IC50 was achieved at this dose of drug. ° and °°: P<0.001.

Mentions: We then studied the effect of Tax on BRCA1-defective and BRCA1-competent cancer cells. Tax is an active microtubule-interfering agent for the treatment of advanced breast cancer. Figure 3Figure 3


BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells.

Tassone P, Tagliaferri P, Perricelli A, Blotta S, Quaresima B, Martelli ML, Goel A, Barbieri V, Costanzo F, Boland CR, Venuta S - Br. J. Cancer (2003)

Differential sensitivity among BRCA1-defective and BRCA1-competent cells to Tax. In (A) HCC1937 cells, (B) MCF-7 cells and (C) MDA-MB231 cells, the dose-related activity of Tax is shown. Interpolate logarithmic curve and the IC50 of cell growth are shown in each quadrant. In (D), the value of IC50 determined for each cell line is shown. *: Maximum of concentration used, no IC50 was achieved at this dose of drug. ° and °°: P<0.001.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2747554&req=5

fig3: Differential sensitivity among BRCA1-defective and BRCA1-competent cells to Tax. In (A) HCC1937 cells, (B) MCF-7 cells and (C) MDA-MB231 cells, the dose-related activity of Tax is shown. Interpolate logarithmic curve and the IC50 of cell growth are shown in each quadrant. In (D), the value of IC50 determined for each cell line is shown. *: Maximum of concentration used, no IC50 was achieved at this dose of drug. ° and °°: P<0.001.
Mentions: We then studied the effect of Tax on BRCA1-defective and BRCA1-competent cancer cells. Tax is an active microtubule-interfering agent for the treatment of advanced breast cancer. Figure 3Figure 3

Bottom Line: HCC1937 cells were significantly (P<0.005) more sensitive to cisplatin (CDDP) (IC(50) : 30-40 microM) compared with MCF-7 (IC(50) : 60-70 microM) and MDA-MB231 (IC(50) : 90-100 microM) cells.Full-length BRCA1 cDNA transfection of BRCA1-defective HCC1937 cells led to the reconstituted expression of BRCA1 protein in HCC1937/(WT)BRCA1-derived cell clone, but did not reduce tumour cell growth in soft agar.BRCA1 reconstitution reverted the hypersensitivity to CDDP (P<0.02), and restored the sensitivity to Dox (P<0.05) and Tax (P<0.001), compared with parental HCC1937 cells.

View Article: PubMed Central - PubMed

Affiliation: Department of Experimental and Clincal Medicine, 'Magna Graecia' University, Italy. tassone@unicz.it

ABSTRACT
Germline mutations of the tumour suppressor gene BRCA1 are involved in the predisposition and development of breast cancer and account for 20-45% of all hereditary cases. There is an increasing evidence that these tumours are characterised by a specific phenotype and pattern of gene expression. We have hypothesised that differences in chemosensitivity might parallel molecular heterogeneity of hereditary and sporadic breast tumours. To this end, we have investigated the chemosensitivity of the BRCA1-defective HCC1937 breast cancer cell line, and the BRCA1-competent MCF-7 (hormone-sensitive) and MDA-MB231 (hormone-insensitive) breast cancer cell lines using the MTT assay. The 50% inhibitory concentration (IC(50)) for the individual compounds were derived by interpolate plot analysis of the logarithmic scalar concentration curve after a 48 h exposure. HCC1937 cells were significantly (P<0.005) more sensitive to cisplatin (CDDP) (IC(50) : 30-40 microM) compared with MCF-7 (IC(50) : 60-70 microM) and MDA-MB231 (IC(50) : 90-100 microM) cells. On the other hand, BRCA1-defective breast cancer cells were significantly less sensitive to doxorubicin (Dox) (IC(50) : 45-50 microM) compared with MCF-7 (IC(50) : 1-5 microM) and MDA-MB231 (IC(50) : 5-10 microM) (P<0.02), as well as to paclitaxel (Tax) (IC(50) : >2 microM for HCC1937, 0.1-0.2 microM for MCF-7 and 0.01-0.02 microM for MDA-MB231) (P<0.001). Full-length BRCA1 cDNA transfection of BRCA1-defective HCC1937 cells led to the reconstituted expression of BRCA1 protein in HCC1937/(WT)BRCA1-derived cell clone, but did not reduce tumour cell growth in soft agar. BRCA1 reconstitution reverted the hypersensitivity to CDDP (P<0.02), and restored the sensitivity to Dox (P<0.05) and Tax (P<0.001), compared with parental HCC1937 cells. Taken together, our findings suggest a specific chemosensitivity profile of BRCA1-defective cells in vitro, which is dependent on BRCA1 protein expression, and suggest prospective preclinical and clinical investigation for the development of tailored therapeutical approaches in this setting.

Show MeSH
Related in: MedlinePlus